These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 14510246)

  • 21. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.
    Daver NG; Shelburne SA; Atmar RL; Giordano TP; Stager CE; Reitman CA; White AC
    J Infect; 2007 Jun; 54(6):539-44. PubMed ID: 17198732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers.
    Buehlmann M; Frei R; Fenner L; Dangel M; Fluckiger U; Widmer AF
    Infect Control Hosp Epidemiol; 2008 Jun; 29(6):510-6. PubMed ID: 18510460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
    Lederer SR; Riedelsdorf G; Schiffl H
    Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection.
    McNeil JC; Kaplan SL; Vallejo JG
    Pediatr Infect Dis J; 2017 Jun; 36(6):572-577. PubMed ID: 28027279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers.
    Ellis MW; Hospenthal DR; Dooley DP; Gray PJ; Murray CK
    Clin Infect Dis; 2004 Oct; 39(7):971-9. PubMed ID: 15472848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methicillin-resistant Staphylococcus aureus osteomyelitis.
    Sheftel TG; Mader JT; Pennick JJ; Cierny G
    Clin Orthop Relat Res; 1985 Sep; (198):231-9. PubMed ID: 4028555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
    Tverdek FP; Crank CW; Segreti J
    Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical vancomycin for chronic suppurative otitis media with methicillin-resistant Staphylococcus aureus otorrhoea.
    Jang CH; Song CH; Wang PC
    J Laryngol Otol; 2004 Aug; 118(8):645-7. PubMed ID: 15453944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome.
    Fang CT; Shau WY; Hsueh PR; Chen YC; Wang JT; Hung CC; Huang LY; Chang SC
    J Antimicrob Chemother; 2006 Mar; 57(3):511-9. PubMed ID: 16443700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
    Park KH; Chong YP; Kim SH; Lee SO; Choi SH; Lee MS; Jeong JY; Woo JH; Kim YS
    J Infect; 2013 Dec; 67(6):556-64. PubMed ID: 23916563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp.
    Ng J; Gosbell IB
    J Antimicrob Chemother; 2005 Jun; 55(6):1008-12. PubMed ID: 15845784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit.
    de la Cal MA; Cerdá E; van Saene HK; García-Hierro P; Negro E; Parra ML; Arias S; Ballesteros D
    J Hosp Infect; 2004 Mar; 56(3):175-83. PubMed ID: 15003664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of routine prophylaxis with vancomycin or cefazolin for femoral neck fracture surgery: microbiological and clinical outcomes.
    Merrer J; Desbouchages L; Serazin V; Razafimamonjy J; Pauthier F; Leneveu M
    Infect Control Hosp Epidemiol; 2006 Dec; 27(12):1366-71. PubMed ID: 17152036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.